These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9690410)

  • 1. Co-administration of cyclosporin enables oral therapy with paclitaxel.
    Meerum Terwogt JM; Beijnen JH; ten Bokkel Huinink WW; Rosing H; Schellens JH
    Lancet; 1998 Jul; 352(9124):285. PubMed ID: 9690410
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral delivery of taxanes.
    Malingré MM; Beijnen JH; Schellens JH
    Invest New Drugs; 2001 May; 19(2):155-62. PubMed ID: 11392449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration.
    Malingré MM; Schellens JH; van Tellingen O; Rosing H; Koopman FJ; Duchin K; Huinink WW; Swart M; Beijnen JH
    Anticancer Drugs; 2000 Nov; 11(10):813-20. PubMed ID: 11142688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced oral bioavailability of docetaxel by coadministration of cyclosporine: quantitation and role of P-glycoprotein.
    Chiou WL; Wu TC; Ma C; Jeong HY
    J Clin Oncol; 2002 Apr; 20(7):1951-2; author reply 1952. PubMed ID: 11919259
    [No Abstract]   [Full Text] [Related]  

  • 6. [Co-delivery of paclitaxel and cyclosporine by a novel liposome-silica hybrid nano-carrier for anti-tumor therapy via oral route].
    Deng L; Su TT; Huang XL; Wang YH; Li C
    Yao Xue Xue Bao; 2014 Jan; 49(1):106-14. PubMed ID: 24783515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A.
    Malingré MM; Beijnen JH; Rosing H; Koopman FJ; van Tellingen O; Duchin K; Ten Bokkel Huinink WW; Swart M; Lieverst J; Schellens JH
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):347-54. PubMed ID: 11345652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients.
    Chu Z; Chen JS; Liau CT; Wang HM; Lin YC; Yang MH; Chen PM; Gardner ER; Figg WD; Sparreboom A
    Anticancer Drugs; 2008 Mar; 19(3):275-81. PubMed ID: 18510173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of oral cyclosporin A when co-administered to enhance the oral absorption of paclitaxel.
    Malingré MM; Ten Bokkel Huinink WW; Duchin K; Schellens JH; Beijnen JH
    Anticancer Drugs; 2001 Aug; 12(7):591-3. PubMed ID: 11487715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.
    Meerum Terwogt JM; Malingré MM; Beijnen JH; ten Bokkel Huinink WW; Rosing H; Koopman FJ; van Tellingen O; Swart M; Schellens JH
    Clin Cancer Res; 1999 Nov; 5(11):3379-84. PubMed ID: 10589748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a thiolated polymer on oral paclitaxel absorption and tumor growth in rats.
    Föger F; Malaivijitnond S; Wannaprasert T; Huck C; Bernkop-Schnürch A; Werle M
    J Drug Target; 2008 Feb; 16(2):149-55. PubMed ID: 18274935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.
    van Asperen J; van Tellingen O; Sparreboom A; Schinkel AH; Borst P; Nooijen WJ; Beijnen JH
    Br J Cancer; 1997; 76(9):1181-3. PubMed ID: 9365166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients.
    Malingré MM; Beijnen JH; Rosing H; Koopman FJ; Jewell RC; Paul EM; Ten Bokkel Huinink WW; Schellens JH
    Br J Cancer; 2001 Jan; 84(1):42-7. PubMed ID: 11139311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and
    Zeng W; Kwan Law BY; Wai Wong VK; Bik Chan DS; Fai Mok SW; Ying Gao JJ; Yan Ho RK; Liang X; Li JH; Lee MT; Yoon WL; Smolinski MP; Nam Lau JY; Kei Lam CW; Fok M
    Cancer Biol Med; 2020 Nov; 17(4):986-1001. PubMed ID: 33299648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of valspodar on the pharmacokinetics of unbound paclitaxel.
    ten Tije AJ; Synold TW; Spicer D; Verweij J; Doroshow JH; Sparreboom A
    Invest New Drugs; 2003 Aug; 21(3):291-8. PubMed ID: 14578679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacokinetic study of oral paclitaxel.
    Malingré MM; Terwogt JM; Beijnen JH; Rosing H; Koopman FJ; van Tellingen O; Duchin K; Huinink WW; Swart M; Lieverst J; Schellens JH
    J Clin Oncol; 2000 Jun; 18(12):2468-75. PubMed ID: 10856107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonist.
    Lush RM; Meadows B; Fojo AT; Kalafsky G; Smith HT; Bates S; Figg WD
    J Clin Pharmacol; 1997 Feb; 37(2):123-8. PubMed ID: 9055138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice.
    Bardelmeijer HA; Ouwehand M; Beijnen JH; Schellens JH; van Tellingen O
    Invest New Drugs; 2004 Aug; 22(3):219-29. PubMed ID: 15122069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-vector strategy bypasses P-glycoprotein efflux, and enhances brain transport and solubility of paclitaxel.
    Blanc E; Bonnafous C; Merida P; Cisternino S; Clair P; Scherrmann JM; Temsamani J
    Anticancer Drugs; 2004 Nov; 15(10):947-54. PubMed ID: 15514563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients.
    Malingré MM; Schellens JH; Van Tellingen O; Ouwehand M; Bardelmeijer HA; Rosing H; Koopman FJ; Schot ME; Ten Bokkel Huinink WW; Beijnen JH
    Br J Cancer; 2001 Nov; 85(10):1472-7. PubMed ID: 11720431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.